Product Name :
IDE1
Description:
IDE1 is an inducer of definitive endoderm 1.
CAS:
1160927-48-9
Molecular Weight:
306.31
Formula:
C15H18N2O5
Chemical Name:
2-[(1E)-[(Z)-(6-carboxy-1-hydroxyhexylidene)amino]iminomethyl]benzoic acid
Smiles :
OC(=O)CCCCC/C(/O)=N/N=C/C1=CC=CC=C1C(O)=O
InChiKey:
ABKJCDILEUEJSH-MHWRWJLKSA-N
InChi :
InChI=1S/C15H18N2O5/c18-13(8-2-1-3-9-14(19)20)17-16-10-11-6-4-5-7-12(11)15(21)22/h4-7,10H,1-3,8-9H2,(H,17,18)(H,19,20)(H,21,22)/b16-10+
Purity:
≥98% (or refer to the Certificate of Analysis)
Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis
Storage Condition :
Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.
Shelf Life:
≥12 months if stored properly.
Stock Solution Storage:
0 – 4 oC for 1 month or refer to the Certificate of Analysis.
Additional information:
IDE1 is an inducer of definitive endoderm 1.|Product information|CAS Number: 1160927-48-9|Molecular Weight: 306.31|Formula: C15H18N2O5|Chemical Name: 2-[(1E)-[(Z)-(6-carboxy-1-hydroxyhexylidene)amino]iminomethyl]benzoic acid|Smiles: OC(=O)CCCCC/C(/O)=N/N=C/C1=CC=CC=C1C(O)=O|InChiKey: ABKJCDILEUEJSH-MHWRWJLKSA-N|InChi: InChI=1S/C15H18N2O5/c18-13(8-2-1-3-9-14(19)20)17-16-10-11-6-4-5-7-12(11)15(21)22/h4-7,10H,1-3,8-9H2,(H,17,18)(H,19,20)(H,21,22)/b16-10+|Technical Data|Appearance: Solid Power|Purity: ≥98% (or refer to the Certificate of Analysis)|Solubility: DMSO : ≥ 30 mg/mL (97.94 mM).|Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis|Storage Condition: Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.GTX-758 Cancer |Shelf Life: ≥12 months if stored properly.CRISPR-Cas9 Protein, S. pyogenes MedChemExpress |Stock Solution Storage: 0 – 4 oC for 1 month or refer to the Certificate of Analysis.PMID:32962453 |Drug Formulation: To be determined|HS Tariff Code: 382200|How to use|In Vitro:|IDE1 enhances the definitive endoderm (DE) differentiation of human-induced pluripotent stem cells (hiPSCs) with Activin A/Wnt3a being significantly more potent in both 2D and 3D cultures compared to IDE1. IDE1 could efficiently induces DE differentiation through various protocols in vitro. Treatment of the hiPSCs-derived EBs with IDE-1 shows minor increase (pProducts are for research use only. Not for human use.|